| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
RemedyMD is the leading provider of registries for life sciences. RemedyMDs highly specific patient and disease registry software and comparative effectiveness research tools enable researchers, clinicians and scientists to collect, aggregate, harmonize, and analyze data from widely disparate sources and then use RemedyMD tools and applications to identify patterns that result in accelerated discoveries, better patient outcomes, and advance translational research.
Glengariff Health Care Ctr is a Glen Cove, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We are pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities. We plan to build a portfolio of plant-identical compounds. Our first compound in development is mescaline.
MPTF is unique as a national model of integrated health and human services and that there is no other such organization dedicated to taking care of a single industry. MPTF has six health centers located in Southern California.